Natco Pharma’s board declared a second interim dividend of ₹1.50 per equity share, with a face value of ₹2, for FY 2024-25.

Operating EBITDA surged 31.7% to ₹435 Crore this quarter from ₹330.2 Crore in Q2 FY24, with EBITDA margin improving to 21.9%, ...

NIA contract valued at ₹136 crore includes demolition, design, construction, and furnishing for four buildings located in ...

The Telangana Stage-II project will further enhance India’s power generation capabilities, boosting infrastructure and ...

The licence authorizes Raneal Advanced Systems to produce, assemble, and test microwave submodules used for command and ...

Discover the benefits of becoming a sub-broker franchise in India. Read about certifications, clients, premises, equipment ...

Bank of India recorded a net profit of Rs 2,374 crore for Q2FY25, a 63% increase over the same time the previous year, ...

The company's EBITDA margins also fell, to 13.9% from 15.6% a year ago, showing persistent challenges on operating efficiency ...

After hitting 105.7 on Monday for the first time since July 3, the U.S. dollar index, which compares the dollar to six others ...

LIC's ownership of NSE-listed companies dropped from 3.64% in the previous quarter to an all-time low of 3.59%.

Over the next five years, 500 compressed biogas plants (CBG) would be established in Andhra Pradesh thanks to an investment ...

Bitcoin's market value surpassed that of well-known corporations like Tesla ($1.123 trillion), Meta Platforms ($1.472 ...